Shares of Teradyne, Inc. (NASDAQ:TER – Get Free Report) rose 10.3% during mid-day trading on Tuesday . The company traded as high as $409.72 and last traded at $403.56. Approximately 4,132,930 shares traded hands during trading, an increase of 6% from the average session volume of 3,882,840 shares. The stock had previously closed at $365.80.
Wall Street Analyst Weigh In
A number of brokerages recently commented on TER. Citigroup boosted their target price on Teradyne from $325.00 to $400.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Morgan Stanley increased their price target on Teradyne from $387.00 to $397.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. The Goldman Sachs Group reissued a “buy” rating and issued a $465.00 price objective on shares of Teradyne in a research note on Tuesday, July 28th. Susquehanna boosted their price objective on Teradyne from $415.00 to $550.00 and gave the company a “positive” rating in a report on Tuesday, June 30th. Finally, UBS Group upped their target price on Teradyne from $440.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Teradyne currently has a consensus rating of “Moderate Buy” and a consensus target price of $396.80.
Read Our Latest Research Report on Teradyne
Teradyne Trading Down 1.2%
Teradyne (NASDAQ:TER – Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $2.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.38. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Teradyne had a return on equity of 39.93% and a net margin of 25.77%.Teradyne’s quarterly revenue was up 103.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.57 earnings per share. Teradyne has set its Q3 2026 guidance at 1.850-2.150 EPS. As a group, research analysts forecast that Teradyne, Inc. will post 9.1 earnings per share for the current year.
Insider Activity at Teradyne
In related news, CEO Gregory Stephen Smith sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $423.03, for a total value of $1,692,120.00. Following the completion of the transaction, the chief executive officer directly owned 120,470 shares of the company’s stock, valued at approximately $50,962,424.10. This trade represents a 3.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shannon John Poulin sold 656 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $355.00, for a total value of $232,880.00. Following the sale, the insider directly owned 15,722 shares in the company, valued at $5,581,310. This trade represents a 4.01% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 14,261 shares of company stock valued at $5,187,344. 0.19% of the stock is currently owned by company insiders.
Institutional Trading of Teradyne
Large investors have recently modified their holdings of the business. Andar Capital Management HK Ltd bought a new position in Teradyne in the second quarter valued at $37,800,000. State Street Corp boosted its position in shares of Teradyne by 0.9% during the fourth quarter. State Street Corp now owns 7,078,635 shares of the company’s stock valued at $1,370,141,000 after purchasing an additional 60,986 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in Teradyne by 3.0% in the second quarter. Ameriprise Financial Inc. now owns 4,920,100 shares of the company’s stock worth $442,413,000 after purchasing an additional 143,058 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in shares of Teradyne by 18.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock valued at $813,640,000 after acquiring an additional 659,273 shares in the last quarter. Finally, Invesco Ltd. raised its holdings in Teradyne by 3.5% in the 3rd quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock worth $407,322,000 after acquiring an additional 99,864 shares during the last quarter. Institutional investors own 99.77% of the company’s stock.
About Teradyne
Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.
The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.
See Also
- Five stocks we like better than Teradyne
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.
